Grainne M. O'Kane, Jennifer L. Spratlin, Malcolm Snow, Michelle A. Jones, Jim Pankovich. "Bold-100-001: A randomized phase 2 study of bold-100 plus FOLFOX vs FOLFOX in patients with refractory metastatic colorectal cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps277